These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17063781)

  • 61. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.
    Villanueva C; Balanzó J; Novella MT; Soriano G; Sáinz S; Torras X; Cussó X; Guarner C; Vilardell F
    N Engl J Med; 1996 Jun; 334(25):1624-9. PubMed ID: 8628357
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding.
    Gournay J; Masliah C; Martin T; Perrin D; Galmiche JP
    Hepatology; 2000 Jun; 31(6):1239-45. PubMed ID: 10827148
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis.
    Zoli M; Marchesini G; Brunori A; Cordiani MR; Pisi E
    Hepatology; 1986; 6(6):1248-51. PubMed ID: 2878867
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of propranolol compared with clonidine on portal haemodynamics: a double-blind cross-over study using duplex-Doppler ultrasonography.
    Tincani E; Cioni G; D'Alimonte P; Cristani A; Turrini F; Romagnoli R; Ventura E
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):893-7. PubMed ID: 8574724
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis.
    Angelico M; Carli L; Piat C; Gentile S; Capocaccia L
    Gastroenterology; 1997 Nov; 113(5):1632-9. PubMed ID: 9352866
    [TBL] [Abstract][Full Text] [Related]  

  • 66. "A la carte" treatment of portal hypertension or just "hors d'oeuvres".
    Blendis L; Lurie Y; Oren R
    Gastroenterology; 2003 Jun; 124(7):1993-5. PubMed ID: 12806642
    [No Abstract]   [Full Text] [Related]  

  • 67. Isosorbide-5-mononitrate in the treatment of pulmonary hypertension associated with portal hypertension.
    Ribas J; Angrill J; Barberà JA; García-Pagán JC; Roca J; Bosch J; Rodriguez-Roisin R
    Eur Respir J; 1999 Jan; 13(1):210-2. PubMed ID: 10836350
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of sublingual isosorbide dinitrate on wedged hepatic venous pressure in cirrhotics with portal hypertension.
    Qureshi H; Zuberi SJ; Faruqui A
    Indian J Gastroenterol; 1988 Jul; 7(3):161-2. PubMed ID: 3397139
    [No Abstract]   [Full Text] [Related]  

  • 69. [CYP2D6 gene polymorphic markers role in determining the optimal treatment tactics for portal hypertension in patients with liver cirrhosis].
    Sychev DA; Parusov AI; Loranskaya ID; Denisenko NP; Akmalova KA; Sozaeva ZA; Turkina OL; Zastrozhin MS
    Ter Arkh; 2022 Feb; 94(2):200-208. PubMed ID: 36286743
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Ultrasound diagnosis of extrahepatic portal hypertension in chronic pancreatitis].
    Kozlov IA; Karmazanovskiĭ GG; Timina IE; Petukhova MV
    Eksp Klin Gastroenterol; 2011; (7):44-52. PubMed ID: 22363999
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Effect of propranolol on renal hemodynamics in patients with cirrhosis: assessment with Doppler US].
    Ozcan H; Aytaç SK; Yağmurlu B; Erten A
    Tani Girisim Radyol; 2004 Sep; 10(3):230-3. PubMed ID: 15470626
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Echo Doppler duplex scanner and color in the study of portal hypertension.
    Buonamico P; Sabbá C
    J Clin Gastroenterol; 1991 Jun; 13(3):342-7. PubMed ID: 2066553
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Optimal use of propranolol in portal hypertension.
    Cales P
    Gastroenterol Clin Biol; 2005 Feb; 29(2):207-8. PubMed ID: 15803523
    [No Abstract]   [Full Text] [Related]  

  • 74. More on Doppler flowmetry and portal hypertension.
    Burns PN; Blei AT
    Gastroenterology; 1988 Jul; 95(1):260-1. PubMed ID: 2967218
    [No Abstract]   [Full Text] [Related]  

  • 75. Propranolol improves endothelial dysfunction in advanced cirrhosis: the 'endothelial exhaustion' hypothesis.
    Brito-Azevedo A; Perez Rde M; Coelho HS; Fernandes Ede S; Castiglione RC; Villela-Nogueira CA; Bouskela E
    Gut; 2016 Aug; 65(8):1391-2. PubMed ID: 26984854
    [No Abstract]   [Full Text] [Related]  

  • 76. Effects of propranolol and nitrates on exercise capacity, respiratory minute volume and capillary oxygen saturation during exercise in cirrhotic patients with portal hypertension.
    Premaratna R; Sathishchandra H; Thilakaratna Y; Shantharaj W; de Silva H
    Hepatol Res; 2002 Oct; 24(2):152. PubMed ID: 12270744
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Portal pressure and Doppler.
    Piscaglia F; Cecilioni L; Gaiani S; Bolondi L
    Ultrasound Med Biol; 2003 Mar; 29(3):495-6. PubMed ID: 12706202
    [No Abstract]   [Full Text] [Related]  

  • 78. Carvedilol--NSBB of choice in all cirrhotics? Short title: Carvedilol for portal hypertension.
    Tandon P; Abraldes JG
    Saudi J Gastroenterol; 2015; 21(5):265-6. PubMed ID: 26458850
    [No Abstract]   [Full Text] [Related]  

  • 79. Ultrasound assessment of splanchnic circulation in Systemic Sclerosis: a non-invasive approach for the study of bowel vasculopathy?
    Bandini G; Accogli E; Cometi L; Matucci-Cerinic M; Moggi Pignone A
    Eur J Intern Med; 2022 Sep; 103():120-121. PubMed ID: 35821193
    [No Abstract]   [Full Text] [Related]  

  • 80. [Comparative study of propranolol versus propranolol plus isosorbide 5-mononitrate in portal hypertension in cirrhotics. Evaluating splanchnic hemodynamics with color Doppler ultrasound].
    Sánchez del Monte J; Ramos Gómez MV; Velazquez Ochoa E
    Rev Gastroenterol Mex; 2005; 70(3):261-8. PubMed ID: 17063781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.